Immunodominance of poxviral-specific CTL in a human trial of recombinant-modified vaccinia Ankara.

Immunodominance of poxviral-specific CTL in a human trial of recombinant-modified vaccinia Ankara.

Many recombinant poxviral vaccines are currently in clinical trials for cancer and infectious diseases. However, these agents have failed to generate T cell responses specific for recombinant gene products at levels comparable with T cell responses associated with natural viral infections. The recen...

Mô tả đầy đủ

Chi tiết về thư mục
Những tác giả chính:	Smith, C, Mirza, F, Pasquetto, V, Tscharke, D, Palmowski, M, Dunbar, P, Sette, A, Harris, A, Cerundolo, V
Định dạng:	Journal article
Ngôn ngữ:	English
Được phát hành:	2005

Những quyển sách tương tự

Recombinant modified vaccinia Ankara primes functionally activated CTL specific for a melanoma tumor antigen epitope in melanoma patients with a high risk of disease recurrence.
Bằng: Smith, C, et al.
Được phát hành: (2005)

Immunodomination during peripheral vaccinia virus infection.
Bằng: Leon C W Lin, et al.
Được phát hành: (2013-01-01)

Mucosal immunization with PLGA-microencapsulated DNA primes a SIV-specific CTL response revealed by boosting with cognate recombinant modified vaccinia virus Ankara.
Bằng: Sharpe, S, et al.
Được phát hành: (2003)

Generation of an immunodominant CTL epitope is affected by proteasome subunit composition and stability of the antigenic protein.
Bằng: Gileadi, U, et al.
Được phát hành: (1999)

Improved Host Range Selection for Recombinant Modified Vaccinia Virus Ankara
Bằng: Caroline Staib, et al.
Được phát hành: (2003-04-01)

Recombinant modified vaccinia virus Ankara efficiently restimulates human cytotoxic T lymphocytes in vitro.
Bằng: Dorrell, L, et al.
Được phát hành: (2000)

Induction of potent antitumor CTL responses by recombinant vaccinia encoding a melan-A peptide analogue.
Bằng: Valmori, D, et al.
Được phát hành: (2000)

New approaches for improving the immunogenicity of modified vaccinia virus Ankara as a recombinant vaccine vector
Bằng: Alharbi, N
Được phát hành: (2014)

Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans.
Bằng: McConkey, S, et al.
Được phát hành: (2003)

Clinical development of Modified Vaccinia virus Ankara vaccines.
Bằng: Gilbert, S
Được phát hành: (2013)

Clinical development of Modified Vaccinia virus Ankara vaccines
Bằng: Gilbert, S
Được phát hành: (2013)

Safety and immunogenicity of novel recombinant BCG and modified vaccinia virus Ankara vaccines in neonate rhesus macaques.
Bằng: Rosario, M, et al.
Được phát hành: (2010)

Immunogenicities of intravenous and intramuscular administrations of modified vaccinia virus Ankara-based multi-CTL epitope vaccine for human immunodeficiency virus type 1 in mice.
Bằng: Hanke, T, et al.
Được phát hành: (1998)

Induction of AIDS virus-specific CTL activity in fresh, unstimulated peripheral blood lymphocytes from rhesus macaques vaccinated with a DNA prime/modified vaccinia virus Ankara boost regimen.
Bằng: Allen, T, et al.
Được phát hành: (2000)

Recombination-mediated genetic engineering of a bacterial artificial chromosome clone of modified vaccinia virus Ankara (MVA).
Bằng: Matthew G Cottingham, et al.
Được phát hành: (2008-02-01)

Dendritic cells infected by recombinant modified vaccinia virus Ankara retain immunogenicity in vivo despite in vitro dysfunction.
Bằng: Behboudi, S, et al.
Được phát hành: (2004)

Recombination-mediated genetic engineering of a bacterial artificial chromosome clone of modified vaccinia virus Ankara (MVA).
Bằng: Cottingham, M, et al.
Được phát hành: (2008)

Selection of Vaccinia Virus Recombinants Using CRISPR/Cas9
Bằng: Anjali Gowripalan, et al.
Được phát hành: (2021-12-01)

Poxviral Ankyrin Proteins
Bằng: Michael H. Herbert, et al.
Được phát hành: (2015-02-01)

Correction: Recombination-Mediated Genetic Engineering of a Bacterial Artificial Chromosome Clone of Modified Vaccinia virus Ankara (MVA).
Bằng: Matthew G. Cottingham, et al.
Được phát hành: (2011-01-01)

Boosting BCG with recombinant modified vaccinia ankara expressing antigen 85A: different boosting intervals and implications for efficacy trials.
Bằng: Ansar A Pathan, et al.
Được phát hành: (2007-10-01)

Transient Host Range Selection for Genetic Engineering of Modified Vaccinia Virus Ankara
Bằng: C. Staib, et al.
Được phát hành: (2000-06-01)

Induction of simian immunodeficiency virus (SIV)-specific CTL in rhesus macaques by vaccination with modified vaccinia virus Ankara expressing SIV transgenes: influence of pre-existing anti-vector immunity.
Bằng: Sharpe, S, et al.
Được phát hành: (2001)

Development of Modified Vaccinia Virus Ankara-Based Vaccines: Advantages and Applications
Bằng: Olga Vladimirovna Orlova, et al.
Được phát hành: (2022-09-01)

Elements in the Development of a Production Process for Modified Vaccinia Virus Ankara
Bằng: Volker Sandig, et al.
Được phát hành: (2013-11-01)

Correction: Recombination-Mediated Genetic Engineering of a Bacterial Artificial Chromosome Clone of Modified Vaccinia virus Ankara (MVA)
Được phát hành: (2011-01-01)

Boosting BCG with Recombinant Modified Vaccinia Ankara Expressing Antigen 85A: Different Boosting Intervals and Implications for Efficacy Trials
Bằng: Pathan, A, et al.
Được phát hành: (2007)

Correction: Boosting BCG with Recombinant Modified Vaccinia Ankara Expressing Antigen 85A: Different Boosting Intervals and Implications for Efficacy Trials.
Bằng: Ansar A. Pathan, et al.
Được phát hành: (2011-01-01)

Boosting BCG with recombinant modified vaccinia ankara expressing antigen 85A: different boosting intervals and implications for efficacy trials.
Bằng: Pathan, A, et al.
Được phát hành: (2007)

Diseño y construcción de vectores de transferencia para la obtención de virus vaccinia Ankara modificado (MVA) recombinantes Design and construction of transfer vectors in order to obtain recombinant modified vaccinia virus Ankara (MVA)
Bằng: M. F. Ferrer, et al.
Được phát hành: (2007-09-01)

Safety and immunogenicity of DNA/modified vaccinia virus ankara malaria vaccination in African adults.
Bằng: Moorthy, V, et al.
Được phát hành: (2003)

Synthetic modified vaccinia Ankara vaccines confer cross-reactive and protective immunity against mpox virus
Bằng: Flavia Chiuppesi, et al.
Được phát hành: (2024-02-01)

Methods of treating Poxviral Infections
Bằng: Ramstedt, U, et al.
Được phát hành: (2011)

Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans.
Bằng: McShane, H, et al.
Được phát hành: (2004)

Induction of antibody responses to African horse sickness virus (AHSV) in ponies after vaccination with recombinant modified vaccinia Ankara (MVA).
Bằng: Rachael Chiam, et al.
Được phát hành: (2009-06-01)

The third generation modified vaccinia Ankara vaccine is effective in preventing the transmission of mpox
Bằng: Mingwang Shen, et al.
Được phát hành: (2024-10-01)

Modified Vaccinia virus Ankara-based vaccines in the era of personalized immunotherapy of cancer
Bằng: Kaïdre Bendjama, et al.
Được phát hành: (2017-09-01)

Hazard Characterization of Modified Vaccinia Virus Ankara Vector: What Are the Knowledge Gaps?
Bằng: Malachy I. Okeke, et al.
Được phát hành: (2017-10-01)

Nodular Dermatitis: Emergence of Novel Poxviral Infection in Russia
Bằng: S. V. Borisevich, et al.
Được phát hành: (2018-04-01)

Enhanced T cell-mediated protection against malaria in human challenges by using the recombinant poxviruses FP9 and modified vaccinia virus Ankara.
Bằng: Webster, D, et al.
Được phát hành: (2005)